Business
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes.
About this update from Cbd Life Sciences Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes\r\n \r\n \r\n\r\n\r\nCBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes\r\n\r\n\r\n\r\n\r\n\r\nThe FDA Authorizes Fruit-Flavored Vapes for Adults 21 and Up Nationwide. CBD Vapes Market size was valued at US$ 5.8 Billion in 2026, and is projected to reach US$ 20.9 Billion by 2033, growing at a CAGR of 20.5% from 2026 to 2033. SCOTTSDALE, AZ / ACCESS Newswire / May 12, 2026 / CBD Life Sciences Inc. (OTCID:CBDL) CBD Life Sciences Inc. is proud to announce our latest product CBD Flavored Vapes that is Nicotine Free. Our CBD Vape flavors are Menthol, Berry, Tropical and Mint. Vaping CBD allows for quick absorption into the bloodstream, leading to faster effects compared to other consumption methods like edibles or oils. Users often report feeling the calming effects within minutes. The CBD Vapes will be available for purchase in the next two weeks. \r\n \r\n \r\n Leadership Perspective: Positioning for Long-Term Growth\r\n \"CBD vapes are emerging as one of the most promising product opportunities in the CBD supplement industry,\" said Lisa Nelson, President and Chief Executive Officer of CBD Life Sciences Inc. \"As ongoing research continues to highlight their potential, we are taking decisive steps to position CBDL as a leader in this growing market. Our commitment remains focused on expanding a strong CBD product ecosystem while creating lasting value for our shareholders.\"\r\n Strategic Alignment with a High-Growth Industry\r\n As the CBD market continues to grow at a rapid pace, CBD vapes are becoming a major point of differentiation for innovative companies. Their non-psychoactive properties, along with rising scientific interest and growing consumer awareness, are fueling increased demand across both retail markets and research-focused sectors.\r\n CBDL believes its early entry and focused investment in CBD product development positions the Company to:\r\n \r\n Capture first-mover advantage in an emerging CBD category\r\n Expand market share across multiple product verticals\r\n Strengthen brand authority in next-generation cannabinoid innovation\r\n Drive long-term revenue growth and shareholder value\r\n \r\n About CBD Life Sciences Inc. (CBDL)\r\n CBD Life Sciences Inc. (OTC:CBDL) is a high-growth innovator in the cann...